Earnings

Walgreens shares fall as pandemic demand slows and health-care investments ramp up

In this article

A person enters a Walgreens store in San Francisco, California, U.S., on Tuesday, April 13, 2021.
David Paul Morris | Bloomberg | Getty Images

Walgreens Boots Alliance on Thursday topped analysts’ expectations for fiscal second-quarter earnings, after the omicron variant intensified demand for Covid booster shots and tests during the winter months.

The drugstore chain reiterated its outlook for the year. It has said that adjusted earnings per share will grow in the low single digits.

Shares rose about 1% in premarket trading.

Here’s what Walgreens reported compared with what analysts were expecting for the second quarter ended Feb. 28, based on Refinitiv data:

  • Earnings per share: $1.59 adjusted vs. $1.40 expected
  • Revenue: $33.76 billion vs. $33.4 billion expected

In the quarter, net income fell to $883 million, or $1.02 per share, from $1.03 billion, or $1.19 per share, in the year-ago period.

Excluding items, the company earned $1.59 per share, exceeding the $1.40 expected by analysts surveyed by Refinitiv.

Sales fell to $33.76 billion from $32.78 billion a year earlier, but surpassed the $33.4 billion that analysts expected.

As of Wednesday’s close, Walgreens shares are down 9% so far this year. Shares closed Wednesday at $47.46, bringing the company’s market value to $40.97 billion.

This story is developing. Please check back for updates.

Products You May Like

Articles You May Like

Is Wash Trading The Next Crypto Scandal?
Bob Iger tells Disney employees they must return to the office four days a week
Goldman Sachs is cutting up to 3,200 employees this week as Wall Street girds for tough year
Set Your Status to Single: 4 Tax Advantages for Solo Filers
FedEx plans more cost cuts as soft demand hurts profits